Provided by Tiger Trade Technology Pte. Ltd.

Sol-Gel Technologies

65.78
+1.081.67%
Post-market: 65.780.00000.00%16:10 EST
Volume:8.17K
Turnover:530.59K
Market Cap:183.25M
PE:-20.39
High:65.78
Open:64.20
Low:63.38
Close:64.70
52wk High:75.00
52wk Low:4.02
Shares:2.79M
Float Shares:689.35K
Volume Ratio:0.22
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2257
EPS(LYR):-3.7979
ROE:-29.59%
ROA:-16.48%
PB:7.04
PE(LYR):-17.32

Loading ...

Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Ltd. Common Shares

Reuters
·
Jan 30

Major Investor Quietly Boosts Stake in Sol-Gel Technologies With Fresh Buy

TIPRANKS
·
Jan 24

Opaleye Management Inc. Acquires Common Shares of Sol Gel Technologies Ltd

Reuters
·
Jan 24

Sol-Gel Technologies Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jan 20

Sol-Gel Technologies: Upside-Driven Buy on SGT-610’s Orphan Gorlin Syndrome Opportunity and Repriced Peak Sales Potential

TIPRANKS
·
Jan 20

Here's Why We're Not At All Concerned With Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation

Simply Wall St.
·
Jan 15

Opaleye Management Inc. Reports Acquisition of Common Shares of Sol Gel Technologies Ltd

Reuters
·
Jan 07

Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Common Shares

Reuters
·
Dec 30, 2025

Sol-Gel Technologies Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Dow Jones
·
Dec 22, 2025

Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Ltd. Common Shares

Reuters
·
Dec 20, 2025

Sol-Gel to End SGT-210 Trial in Darier Disease

MT Newswires Live
·
Dec 18, 2025

Why Is Small Cap Sol-Gel Tech Stock Falling Today?

Benzinga_recent_news
·
Dec 18, 2025

Sol Gel Technologies Ltd - Phase 1B Study of Sgt-210 Shows No Differentiation From Vehicle

THOMSON REUTERS
·
Dec 17, 2025

Sol Gel Technologies Ltd - Sol-Gel Decides Not to Advance Sgt-210 to Next Development Stage

THOMSON REUTERS
·
Dec 17, 2025

Sol Gel Technologies Ltd - Continue to Prioritize Phase 3 Program of Sgt-610 in Gorlin Syndrome

THOMSON REUTERS
·
Dec 17, 2025

Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease

GlobeNewswire
·
Dec 17, 2025

Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares

Reuters
·
Dec 17, 2025

Opaleye Management Acquires Common Shares of Sol Gel Technologies Ltd

Reuters
·
Dec 10, 2025

Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Ltd. Common Shares

Reuters
·
Dec 04, 2025

Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares

Reuters
·
Nov 27, 2025